eMedTalks Series: Chelation Therapy Data Review & Development: An Inside Look

​​​​​About the Webinar:

The National Institutes of Health authorized a $37 million grant for Dr. Gervasio Lamas to conduct a follow-up study to determine whether chelation is as beneficial as conventional therapies — or more so — in preventing heart attacks in diabetics.

The five-year study started in 2016— the Trial to Assess Chelation Therapy (TACT2) —involves researchers at more than 100 other leading medical institutions in the U.S. and Canada.

This webinar will cover TACT 2 and TACT 3, as well as the data that is currently showing that people with vascular disease have a total body burden of excessive metals.   We will discuss Calcium vs Sodium EDTA differences with respect to metals.   Find out the different delivery options currently being used, including suppository forms. 

About the Speaker:

Dr. Dorothy F. Merritt has practiced medicine for 30 years. Dr. Merritt graduated from the University of Kansas School of Medicine in 1984. She practices medicine in Texas City, TX and specializes in Internal Medicine. Merritt was a TACT trial Principal investigator and was named one of the Top 20 alternative med docs by AIHIMA IN 2014.​​​​​​​

  • American College for Advancement in Medicine

    Webinar Host

  • Dorothy Merritt, MD


  • Allen Green, MD


  • , ,